Mode
Text Size
Log in / Sign up
N/A N=60 Randomized Single-blind Treatment

A PPG Sensor-Based Feedback Intervention for Heavy Drinking Young Adults

Heavy Drinking · Harmful; Use, Alcohol

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Total Drinks Consumed — 6.76; 7.07 drinks — p=<0.0001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Behavioral Self-Management and Feedback (Behavioral); Behavioral Self-Management (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Jun 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Total Drinks Consumed
6.76; 7.07 <0.0001 sig
SECONDARY
Drinks Per Drinking Day
2.26; 2.34 <0.0001 sig
SECONDARY
Percent Heavy Drinking Days
18.62; 19.83 <0.0001 sig
SECONDARY
Percent Abstinent Days
66.04; 65.56 <0.0001 sig
SECONDARY
Alcohol-related Consequences
8.56; 8.23 <.0001 sig
SECONDARY
Sleep Quality
50.59; 50.38 <.0001 sig
SECONDARY
Sleep-related Impairment
53.98; 55.05 <.0001 sig
SECONDARY
Sleep Duration
168.73; 170.78; 172.18; 169.38; 171.74; 170.11 0.02 sig
SECONDARY
Heart Rate Variability (HRV)
7.55; 7.79; 7.63; 7.81; 7.68; 7.84 0.0001 sig
SECONDARY
Lowest Resting Heart Rate (RHR)
4.06; 4.03; 4.06; 4.03; 4.05; 4.03 0.04 sig

Summary

Heavy alcohol use among young adults is a significant public health problem. Advances in technology may offer an innovative solution. This project will conduct the first controlled test of a feedback intervention for reducing drinking and improving health in young adults by targeting heart rate variability, resting heart rate, and sleep via biosensors and electronic diary methods.

Eligibility Criteria

Inclusion Criteria

  • 18-25 years of age
  • Report ≥ 4 heavy drinking occasions in the past 28 days
  • Report Alcohol Use Disorders Identification Test- Consumption (AUDIT-C) scores indictive of risk of drinking harm
  • English Speaking
  • Have a personal smartphone

Exclusion Criteria

  • Sleep Disorder History
  • Night/ Rotating work shift
  • Travel two or more time zones in the month prior to the study or anticipated travel two or more times during study participation
  • Clinically severe AUD in past 12 months
  • Currently enrolled in alcohol or sleep treatment
  • Current, severe psychiatric illness
  • Current DSM-V substance use disorder
  • Positive urine drug screen for a substance other than marijuana
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05090995). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search